Back to Search
Start Over
Standardization of 13-color high-sensitivity measurable residual disease (MRD) assessment in B-cell lymphoblastic leukemia (B-ALL) treated with novel anti-CD19 immunotherapies
- Source :
- Pediatric Hematology Oncology Journal, Vol 7, Iss 4, Pp S14- (2022)
- Publication Year :
- 2022
- Publisher :
- Elsevier, 2022.
- Subjects :
- Pediatrics
RJ1-570
Subjects
Details
- Language :
- English
- ISSN :
- 24681245
- Volume :
- 7
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Pediatric Hematology Oncology Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.f5c2c4b7519d4c49817905bcbde6c1a5
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.phoj.2022.10.028